Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses.

Behavioural Brain Research
Santosh Kumar Prajapati, Sairam Krishnamurthy

Abstract

Post-traumatic stress disorder (PTSD) is a psychological disorder affecting many around the world. Growing evidence suggests that orexin-A is involved in the pathophysiology of depression and panic anxiety disorder. However, the role of orexin-A in PTSD remains unclear. Therefore, pharmacological manipulation of orexin-A can be a potential approach for the treatment of PTSD. Male Wistar rats were subjected to stress re-stress (SRS) by restraining them for 2 h followed by foot shock (FS) and halothane exposure on day-2 (D-2). Then the rats were weekly exposed to FS as re-stress cue . Suvorexant, an orexin antagonist (10, 20 and 30 mg/kg p.o.) and paroxetine (10 mg/kg p.o.) were administered from D-8 to D-32. Plasma and cerebrospinal fluid (CSF) were collected for corticosterone and orexin-A measurement. The analysis of serotonin and corticotropin-releasing factor receptor-1 (CRF-R1) were performed in the amygdalar tissue. SRS-induced PTSD-like symptoms like fear response, anxiety-like behaviour and hypocorticosteronism were attenuated by suvorexant and paroxetine. Interestingly, SRS exposed rats showed activation of orexin-A and serotonergic systems, which were also attenuated by suvorexant. Additionally, suvorexant ameliorated ...Continue Reading

References

May 27, 1991·Neuroscience Letters·C RampinM Jouvet
Feb 1, 1993·Pharmacology, Biochemistry, and Behavior·D TreitC Royan
Apr 1, 1993·Biological Psychiatry·R Yehuda, S M Antelman
Aug 5, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F ChaouloffP Mormède
Mar 29, 2000·Biochemical and Biophysical Research Communications·T IdaN Murakami
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Ann C Schwartz, Barbara O Rothbaum
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Tracy L Bale, Wylie W Vale
Dec 17, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Raphaëlle Winsky-SommererLuis de Lecea
Oct 13, 2006·Psychopharmacology·Terumichi TakahashiShigeto Yamawaki
Dec 29, 2009·Nature Medicine·Philip L JohnsonAnantha Shekhar
Apr 9, 2011·Journal of Neurogenetics·Christopher J WinrowJohn J Renger
Oct 25, 2011·Neuropharmacology·Christopher J WinrowJohn J Renger
Oct 5, 2012·American Journal of Physiology. Cell Physiology·Jyrki P Kukkonen
Dec 25, 2012·Trends in Neurosciences·Andrew Holmes, Nicolas Singewald
Jul 31, 2013·Neuropharmacology·Sairam KrishnamurthyKeerikkattil P Joy
Aug 6, 2013·Frontiers in Psychiatry·Subhashini SrinivasanSelena E Bartlett
Oct 1, 2013·Journal of Anxiety Disorders·Simone WhiteAnanda B Amstadter
Mar 5, 2014·Frontiers in Neuroscience·Emilio Merlo Pich, Sergio Melotto
Mar 13, 2014·Frontiers in Neuroscience·Jiann Wei YeohChristopher V Dayas
Jun 17, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·África FloresFernando Berrendero
Dec 3, 2014·The Psychiatric Clinics of North America·Polaris Gonzalez, Karen G Martinez
Jan 15, 2015·The Journal of Pharmacology and Experimental Therapeutics·Pascal BonaventureChristine Dugovic
May 15, 2015·Journal of Pharmacology & Pharmacotherapeutics·Ashok K DubeyPramod K Mediratta
Jul 29, 2015·Trends in Neurosciences·África FloresFernando Berrendero
Jan 6, 2016·Indian Journal of Pharmacology·Shatavisa MukherjeeSantanu Kumar Tripathi
Jan 6, 2017·The Journal of Physiological Sciences : JPS·Mariko SoYoichi Ueta
Mar 30, 2017·Frontiers in Psychiatry·Iro FragkakiMuriel A Hagenaars
Jul 14, 2018·Frontiers in Molecular Neuroscience·Chunmei WangJing Chen
Jul 10, 2019·Neuropsychopharmacology Reports·Taro KishiNakao Iwata
Sep 4, 2019·Physiology & Behavior·Santosh Kumar PrajapatiSairam Krishnamurthy

❮ Previous
Next ❯

Citations

May 1, 2021·International Journal of Molecular Sciences·Satoshi FujisawaFumio Otsuka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Related Papers

Australian Prescriber
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
J A AdamJ W M Greve
Regulatory Toxicology and Pharmacology : RTP
Stephanie BornRichard Briscoe
© 2021 Meta ULC. All rights reserved